Sedation and analgosedation (PSA) in pediatric patients - evaluation of new procedure for the documentation of complications

Sedation and analgosedation (PSA) in pediatric patients - evaluation of new procedure for the documentation of complications - PSA in pediatric patients - a new procedure for the documentation of complications

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00029926

Enrollment

700

Registered

2022-07-29

Start date

2022-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Documenataion of potential complications and of possible interventions during PSA of pediatric patients.

Interventions

Group 1: Evaluation of a new procedure for the efficient documentation of potential complications and possible interventions during PSA of pediatric patients. Respiratory complications: - Deviation f

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: - All pediatric patients (age 12 years) for analysis of the sedation protocol.

Exclusion criteria

Exclusion criteria: Age > 18 years. - Missing written consent by parents/legal guardian and by the capable patient (approx. > 12 years) for analysis of the sedation protocol.

Design outcomes

Primary

Measure	Time frame
Evaluation of a new procedure for the efficient documentation of potential complications and possible interventions during PSA of pediatric patients. ==> Analysis of sedation protocols	—

Countries

Germany

Contacts

Public ContactHarald Sauer

Universitätsklinikum des SaarlandesKliniken für Kinder- und Jugendmedizin

harald.sauer@uks.eu004968411628374

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026